ATE324883T1
Pharmaceutical compostion comprising lumiracoxib
Abstract
This record has no abstract on file.
Term
Term ended
Projected expiry passed 30 August 2022, 4.1 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
113 members in 30 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 31638901 | United States of America | P |
Members113
| Document | Office | Kind | |
|---|---|---|---|
| CA2425112A1 | Canada | A1 | |
| WO0229003A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU9664501A | Australia | A | |
| WO0229003A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2002102586A1 | United States of America | A1 | |
| CA2456604A1 | Canada | A1 | |
| WO03020261A1 | World Intellectual Property Organization (WIPO) | A1 | |
| PE20030323A1 | Peru | A1 | |
| US2003114527A1 | United States of America | A1 | |
| EP1337541A2 | European Patent Office (EPO) | A2 | |
| US6664079B2 | United States of America | B2 | |
| JP2004510433A | Japan | A | |
| KR20040031019A | Republic of Korea | A | |
| NO20040860L | Norway | L | |
| ECSP044986A | Ecuador | A | |
| EP1425005A1 | European Patent Office (EPO) | A1 | |
| MXPA04001933A | Mexico | A | |
| BR0212155A | Brazil | A | |
| EP1337541A4 | European Patent Office (EPO) | A4 | |
| IL160375A0 | Israel | A0 | |
| IL160375D0 | Israel | D0 | |
| AR036312A1 | Argentina | A1 | |
| US2004185466A1 | United States of America | A1 | |
| ZA200400877B | South Africa | B | |
| HU0401429A2 | Hungary | A2 | |
| HUP0401429A2 | Hungary | A2 | |
| PL367464A1 | Poland | A1 | |
| RU2004109920A | Russian Federation | A | |
| JP2005520785A | Japan | A | |
| CO5560554A2 | Colombia | A2 | |
| NZ531342A | New Zealand | A | |
| CN1728993A | China | A | |
| EP1425005B1 | European Patent Office (EPO) | B1 | |
| DE60211183D1 | Germany | D1 | |
| AT324883T | Austria | T | |
| ATE324883T1This record | Austria | T1 | |
| AU2002331094B2 | Australia | B2 | |
| DK1425005T3 | Denmark | T3 | |
| PT1425005E | Portugal | E | |
| HK1087336A | Hong Kong, China | A | |
| HK1087336A1 | Hong Kong, China | A1 | |
| ES2263813T3 | Spain | T3 | |
| SI1425005T1 | Slovenia | T1 | |
| DE60211183T2 | Germany | T2 | |
| EP1337541B1 | European Patent Office (EPO) | B1 | |
| AT356222T | Austria | T | |
| ATE356222T1 | Austria | T1 | |
| DE60127162D1 | Germany | D1 | |
| EP1790736A2 | European Patent Office (EPO) | A2 | |
| DE20122767U1 | Germany | U1 | |
| EP1790736A3 | European Patent Office (EPO) | A3 | |
| US2007231382A1 | United States of America | A1 | |
| US7345159B2 | United States of America | B2 | |
| DE60127162T2 | Germany | T2 | |
| US2008131895A1 | United States of America | A1 | |
| RU2329801C2 | Russian Federation | C2 | |
| CN100406008C | China | C | |
| US2008199868A1 | United States of America | A1 | |
| US2008319179A1 | United States of America | A1 | |
| MY137516A | Malaysia | A | |
| KR100895551B1 | Republic of Korea | B1 | |
| US7635578B2 | United States of America | B2 | |
| US7713698B2 | United States of America | B2 | |
| US7790869B2 | United States of America | B2 | |
| US2010317012A1 | United States of America | A1 | |
| CA2456604C | Canada | C | |
| JP4636796B2 | Japan | B2 | |
| CY1106137T1 | Cyprus | T1 | |
| CA2425112C | Canada | C | |
| US8088575B2 | United States of America | B2 | |
| US2012142006A1 | United States of America | A1 | |
| US2013096015A1 | United States of America | A1 | |
| US2014206553A1 | United States of America | A1 | |
| US2015197800A1 | United States of America | A1 | |
| US9133511B2 | United States of America | B2 | |
| EP3034627A1 | European Patent Office (EPO) | A1 | |
| US2016264612A1 | United States of America | A1 | |
| US2017088574A1 | United States of America | A1 | |
| US2017088575A1 | United States of America | A1 | |
| US2017088891A1 | United States of America | A1 | |
| US2017190730A2 | United States of America | A2 | |
| US9708358B2 | United States of America | B2 | |
| US9718852B2 | United States of America | B2 | |
| US9719139B2 | United States of America | B2 | |
| US9725480B2 | United States of America | B2 | |
| HK1227441A | Hong Kong, China | A | |
| HK1227441A1 | Hong Kong, China | A1 | |
| US2017313737A1 | United States of America | A1 | |
| US9868985B2 | United States of America | B2 | |
| US2018201642A1 | United States of America | A1 | |
| EP3034627B1 | European Patent Office (EPO) | B1 | |
| US2019031704A1 | United States of America | A1 | |
| US2019031705A1 | United States of America | A1 | |
| US2019031706A1 | United States of America | A1 | |
| US2019085014A1 | United States of America | A1 | |
| US2019085015A1 | United States of America | A1 | |
| US2019085016A1 | United States of America | A1 | |
| US2019092805A1 | United States of America | A1 | |
| US2019092806A1 | United States of America | A1 | |
| US2019135850A1 | United States of America | A1 |
Showing 100 of 113
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP | |
| Change in the person of patent ownerEEIH | EEIH |
Numbers
- Application
- 2767455
Titles2
- German
- PHARMAZEUTISCHE ZUSAMMENSETZUNG ENTHALTEND LUMIRACOXIB
- English
- PHARMACEUTICAL COMPOSITION CONTAINING LUMIRACOXIB
Classification
- CPC, 3
- A61K31/196
- A61P29/00
- A61P43/00
- IPC, 13
- A61K9 20
- A61K
- A61K9 22
- A61K31 195
- A61K31 196
- A61K47 12
- A61K47 32
- A61K47 36
- A61K47 38
- A61P
- A61P29 00
- A61P43 00
- C07C